GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Impedimed Ltd (OTCPK:IPDQF) » Definitions » Growth Rank

IPDQF (Impedimed) Growth Rank : 0 (As of Apr. 16, 2025)


View and export this data going back to . Start your Free Trial

What is Impedimed Growth Rank?

Impedimed has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


Impedimed Growth Rank Related Terms

Thank you for viewing the detailed overview of Impedimed's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Impedimed Business Description

Traded in Other Exchanges
Address
50 Parker Court, Unit 1, Pinkenba, QLD, AUS, 4008
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognizes revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.

Impedimed Headlines

From GuruFocus

Q2 2021 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2020 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2023 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Ltd Corporate Call Transcript

By GuruFocus Research 02-14-2024

Q2 2022 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

ImpediMed Ltd Ordinary Shareholders Meeting Transcript

By GuruFocus Research 09-14-2024

Q4 2021 ImpediMed Ltd Business Results Call Transcript

By GuruFocus Research 02-14-2024

Q1 2023 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2022 ImpediMed Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2024 ImpediMed Ltd Activities Report Call Transcript

By GuruFocus Research 09-14-2024